Status:
COMPLETED
The BOOSTED (Booster Options Or Switching Tested for Effectiveness and Downsides Study) Trial (COVID-19)
Lead Sponsor:
University of California, San Francisco
Conditions:
COVID-19
Vaccine Reaction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
While both heterologous (mixing) and homologous (matching) vaccine regimens are now considered standard of care, post-vaccination complications and long-term effects of the different vaccination regim...
Detailed Description
The FDA recently approved the use of COVID-19 booster vaccines for both homologous and heterologous vaccine booster regimens, with both regimens considered standard of care. However, there is incomple...
Eligibility Criteria
Inclusion
- Must be enrolled in the COVID19 Citizen Science (CCS) study. The CCS study is a remote, longitudinal, observational registry hosted on the Eureka Research Platform that administers weekly questionnaires to participants regarding COVID-19 symptoms and exposures. CCS is currently open to enrollment for adults aged 18 and older who have a smartphone device to participate on the mobile app, or an email address to participate on the web portal.
- Must have received either 2 doses of mRNA vaccine such as Moderna and Pfizer, or 1 dose of Johnson and Johnson
Exclusion
- Already received a COVID19 booster
- Are not planning on receiving a COVID19 booster in the next 3 months
- Do not have equal access to both the Pfizer and Moderna boosters
- Have a medical reason to receive either the Pfizer or Moderna booster
- Have a medical reason to not receive any booster (e.g h/o allergic reaction to an mRNA vaccine or myocarditis or pericarditis after an mRNA vaccine)
- Are unwilling to be randomized
- Are unable to commit to filling out the CCS weekly surveys consistently (to the best of their ability)
Key Trial Info
Start Date :
January 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 18 2023
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT05268185
Start Date
January 18 2022
End Date
January 18 2023
Last Update
February 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Parnassus
San Francisco, California, United States, 94143